Type
Business expansion
Country
France
Region
Est; Alsace; Bas-Rhin
Location of affected unit(s)
Molsheim
Sector
Manufacturing
Manufacturing Of Furniture And Other Manufacturing
Other Manufacturing
32.50 - Manufacture of medical and dental instruments and supplies

350 jobs
Number of planned job creations
Job creation
Announcement Date
17 March 2021
Employment effect (start)
17 March 2021
Foreseen end date

Description

The German pharmaceutical group Merck has announced the recruitment of 350 employees, including 80 in 2021, at its site in Molsheim (Bas-Rhin) which specialises in the manufacture of tools for the detection of microbiological pollutants.

The group announces an investment of €25 million to develop the site's production capacity from 2021. The investment will be destined to the creation of a new production unit for 'single-use assemblies', that is watertight bags are used in the manufacturing process of vaccines, such as those currently being developed against COVID-19. 

Merck Molsheim employs than 1,700 and it is the group's third largest site worldwide. Currently, the site has three production units representing its three major activities: BioMonitoring, Lab Water Solutions & Instruments, and Systems and Solutions.


Sources

Citation

Eurofound (2021), Merck, Business expansion in France, factsheet number 104488, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/104488.